Monday November 23 2009 | Biotechnology feed | All feeds
|
|
HYD Ltd. for Research and Development
Download detailed PDF Members: HYD Ltd. for Research and Development, a technology based pharmaceutical company was established in 1992 to develop pharmaceuticals and consumer products that utilize a novel proprietary procedure, Deuterium Depletion for the treatment and prophylaxis of various types of cancer and other proliferative and neoplastic diseases. Deuterium Depletion opens new perspectives in cancer treatment and prevention offering a completely safe and non- invasive treatment modality. In Hungary all research and development, including drug registration and other product development, based on the Deuterium Depletion technology is exclusively managed, organised and financed by HYD Ltd. for Research and Development.
This page has been viewed 460 times since April 2007, the link to the organisation's website has been followed 72 times Search for more companies in Budapest This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for HYD Ltd. for Research and Development | |||||||||||||||||||||||||||||||||||||||||
|